A large proportion of patients with asthma have asthma that is uncontrolled. Many of these patients have symptoms that are uncontrolled despite maximizing available inhaled therapy options. In this 1-hour webcast, national asthma experts review management of severe and uncontrolled asthma, providing detailed insight into the utilization of asthma endotype and phenotype classifications and patient-specific factors for appropriate add-on biologic selection to improve asthma control.
In Collaboration With the Association of Pulmonary Advanced Practice Providers
In Collaboration With the National Association of Pediatric Nurse Practitioners
Interactive video lecture
After completing this activity, participants should be better able to:
- Classify uncontrolled asthma based on phenotypes and endotypes
- Identify appropriate treatment options with add-on biologic therapy
- Modify treatment plans based on individual patient- and disease-focused elements
NPs and PAs in pulmonary medicine
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until January 27, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA Course Advisor: John Hardisty, MS, MSPAS, PA-C, Colorado Springs Pulmonary Consultants, Colorado Springs, Colorado
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program is cosupported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; Genentech, a member of the Roche Group; GlaxoSmithKline; Jazz Pharmaceuticals, Inc.; and Mylan Specialty L.P.
This activity is supported by educational grants from Genentech, a member of the Roche Group; and GlaxoSmithKline.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
Ms Hefel has no relevant financial relationships to disclose.
Dr Liu: contracted research: GlaxoSmithKline, Gossamer Bio; consulting fees: AstraZeneca, GlaxoSmithKline, Gossamer Bio
Ms Young has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the evaluation form
The estimated time to complete this activity is 1.00 hour.
Release date: January 28, 2022
Expiration date: January 27, 2023
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 103121PBC-7A